Literature DB >> 10940250

The structural biology of molecular recognition by vancomycin.

P J Loll1, P H Axelsen.   

Abstract

Vancomycin is the archetype among naturally occurring compounds known as glycopeptide antibiotics. Because it is a vital therapeutic agent used world-wide for the treatment of infections with gram-positive bacteria, emerging bacterial resistance to vancomycin is a major public health threat. Recent investigations into the mechanisms of action of glycopeptide antibiotics are driven by a need to understand their detailed mechanism of action so that new agents can be developed to overcome resistance. These investigations have revealed that glycopeptide antibiotics exhibit a rich array of complex cooperative phenomena when they bind target ligands, making them valuable model systems for the study of molecular recognition.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940250     DOI: 10.1146/annurev.biophys.29.1.265

Source DB:  PubMed          Journal:  Annu Rev Biophys Biomol Struct        ISSN: 1056-8700


  25 in total

1.  Inhibition of the autolytic system by vancomycin causes mimicry of vancomycin-intermediate Staphylococcus aureus-type resistance, cell concentration dependence of the MIC, and antibiotic tolerance in vancomycin-susceptible S. aureus.

Authors:  Krzysztof Sieradzki; Alexander Tomasz
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Computational design of an endo-1,4-beta-xylanase ligand binding site.

Authors:  Andrew Morin; Kristian W Kaufmann; Carie Fortenberry; Joel M Harp; Laura S Mizoue; Jens Meiler
Journal:  Protein Eng Des Sel       Date:  2011-02-24       Impact factor: 1.650

3.  The Carboxyl Terminus of Eremomycin Facilitates Binding to the Non-d-Ala-d-Ala Segment of the Peptidoglycan Pentapeptide Stem.

Authors:  James Chang; Hongyu Zhou; Maria Preobrazhenskaya; Peng Tao; Sung Joon Kim
Journal:  Biochemistry       Date:  2016-06-07       Impact factor: 3.162

4.  The effect of environment on the recognition and binding of vancomycin to native and resistant forms of lipid II.

Authors:  ZhiGuang Jia; Megan L O'Mara; Johannes Zuegg; Matthew A Cooper; Alan E Mark
Journal:  Biophys J       Date:  2011-12-07       Impact factor: 4.033

5.  Host-guest chemistry of the peptidoglycan.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  J Med Chem       Date:  2010-07-08       Impact factor: 7.446

Review 6.  Molecular engineering of an orthopaedic implant: from bench to bedside.

Authors:  I M Shapiro; N J Hickok; J Parvizi; S Stewart; T P Schaer
Journal:  Eur Cell Mater       Date:  2012-05-24       Impact factor: 3.942

7.  Vancomycin forms ligand-mediated supramolecular complexes.

Authors:  Patrick J Loll; Ariss Derhovanessian; Maxim V Shapovalov; Jeffrey Kaplan; Lin Yang; Paul H Axelsen
Journal:  J Mol Biol       Date:  2008-11-01       Impact factor: 5.469

Review 8.  Glycopeptide antibiotics: from conventional molecules to new derivatives.

Authors:  Françoise Van Bambeke; Yves Van Laethem; Patrice Courvalin; Paul M Tulkens
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Structure of ristocetin A in complex with a bacterial cell-wall mimetic.

Authors:  Virginie Nahoum; Sherri Spector; Patrick J Loll
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-07-17

10.  Polymerizable vancomycin derivatives for bactericidal biomaterial surface modification: structure-function evaluation.

Authors:  McKinley C Lawson; Richard Shoemaker; Kevin B Hoth; Christopher N Bowman; Kristi S Anseth
Journal:  Biomacromolecules       Date:  2009-08-10       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.